The World Health Organization made a unique proposition: what if big donors pooled resources to take out private insurance to pay for vaccines in the case of a bird flu pandemic? WHO Director-General Dr Margaret Chan said WHO had been given more preparation time than it could have hoped for ahead of an influenza pandemic. WHO is using that time to study various financing options to allow low income countries to access vaccines and prevent a pandemic catastrophe that could kill millions of people.
Public-Private Mix
Advocacy on engaging the private sector in tuberculosis (TB) control is mounting. In the newly launched six-point Stop TB Strategy, WHO makes an urgent appeal to engage private care providers. Even more recently, this was supplanted by a guide on how to involve all care providers in TB control through different Public-Private Mix (PPM) approaches. At the same time the body of evidence on the effectiveness of such approaches, although growing, remains rather weak.
This paper by the AIDS Law Project calls for measures to address inequity in access to private health care services and to regulate costs in the private sector. For this reason regular and accurate information about health financing, service prices and business practices in the private sector is essential in determining both health policy as well as a fair and reasonable price for services and products.
In many countries, private health care providers are the gateway to health services for people with symptoms of TB. The types of private providers and their roles in TB management, however, vary greatly across and within countries. The traditional healers in Malawi, unqualified practitioners in India or hospital-based chest physicians in Indonesia are all, for example, private health care providers in their respective settings with current and potential roles in TB control.
The ability of health organizations in developing countries to expand access to quality services depends in large part on organisational and human capacity. Capacity building includes professional development of staff, as well as efforts to create working environments conducive to high levels of performance. The current study evaluated an approach to public-private partnership where corporate volunteers give technical assistance to improve organizational and staff performance. From 2003 to 2005, the Pfizer Global Health Fellows program sent 72 employees to work with organizations in 19 countries. This evaluation was designed to assess program impact.
Global malaria control strategies highlight the need to increase early uptake of effective antimalarials for childhood fevers in endemic settings, based on a presumptive diagnosis of malaria in this age group. Many control programmes identify private medicine sellers as important targets to promote effective early treatment, based on reported widespread inadequate childhood fever treatment practices involving the retail sector. Data on adult use of over-the-counter (OTC) medicines is limited. This study aimed to assess childhood and adult patterns of OTC medicine use to inform national medicine retailer programmes in Kenya and other similar settings.
Between 6.5 and 11 million people are in need of antiretroviral therapy (ART) in developing countries. Only 1.3 million are receiving it. With the public sector struggling to expand coverage, how can the private sector play a more significant role? This paper reviews the experiences of franchising and its potential for HIV and AIDS services.
This policy research brief draws on the findings of a UNDP-supported book, Privatization and Alternative Public Sector Reform in Sub-Saharan Africa (Bayliss and Fine, forthcoming), to analyse the effects of privatisation on the delivery of water and electricity. Its chief conclusion? Privatisation has been a widespread failure. This has hampered progress on the MDGs for both water and sanitation, and on many other MDGs dependent on energy. Privatisation has failed on several counts. Contrary to expectations, private investors have shied away from investing in such utilities in the region. So it has been costly for governments to motivate them to invest. Moreover, the focus of investors on cost recovery has not promoted social objectives, such as reducing poverty and promoting equity. Thus, current realities dictate refocusing on building up the capacity of the public sector. It continues to dominate the provision of water and electricity, and will do so for the foreseeable future. But a dramatic scaling up of both external and domestic resources will be needed to finance more extensive public investment in these sectors. This approach is consistent with the current priority of adopting more ambitious MDG-based development strategies in the region.
The ability of health organizations in developing countries to expand access to quality services depends in large part on organizational and human capacity. Capacity building includes professional development of staff, as well as efforts to create working environments conducive to high levels of performance. The current study evaluated an approach to public-private partnership where corporate volunteers give technical assistance to improve organizational and staff performance. From 2003 to 2005, the Pfizer Global Health Fellows program sent 72 employees to work with organizations in 19 countries. This evaluation was designed to assess program impact.
This paper describes the context of health care provision in sub-Saharan Africa (SSA), analyses current mechanisms for public-private partnerships (PPP), and discusses emerging issues in strengthening partnerships to expand health coverage.